Seroatlas · Human Serome Atlas

CC2D1A

Coiled-coil and C2 domain-containing protein 1A

Also known as: Aki-1, C2D1A_HUMAN, FLJ20241, Freud-1, Lgd2, MRT3, TAPE

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q6P1N0
Gene
CC2D1A
Ensembl
ENSG00000132024
Chromosome
19
Canonical length
951 aa
Protein class
Disease related genes, Human disease related genes, Predicted intracellular proteins
Subcellular location
Nucleoli fibrillar center,Plasma membrane,Basal body,Cytosol

OverviewNCBI Gene

This gene encodes a transcriptional repressor that binds to a conserved 14-bp 5'-repressor element and regulates expression of the 5-hydroxytryptamine (serotonin) receptor 1A gene in neuronal cells. The DNA binding and transcriptional repressor activities of the protein are inhibited by calcium. A mutation in this gene results in a nonsyndromic form of cognitive disability (MRT3). [provided by RefSeq, Jul 2017]

Canonical amino-acid sequenceUniProt

951 residues, UniProt reviewed canonical sequence.

>Q6P1N0|CC2D1A
     1  MHKRKGPPGP PGRGAAAARQ LGLLVDLSPD GLMIPEDGAN DEELEAEFLA LVGGQPPALE
    61  KLKGKGPLPM EAIEKMASLC MRDPDEDEEE GTDEDDLEAD DDLLAELNEV LGEEQKASET
   121  PPPVAQPKPE APHPGLETTL QERLALYQTA IESARQAGDS AKMRRYDRGL KTLENLLASI
   181  RKGNAIDEAD IPPPVAIGKG PASTPTYSPA PTQPAPRIAS APEPRVTLEG PSATAPASSP
   241  GLAKPQMPPG PCSPGPLAQL QSRQRDYKLA ALHAKQQGDT TAAARHFRVA KSFDAVLEAL
   301  SRGEPVDLSC LPPPPDQLPP DPPSPPSQPP TPATAPSTTE VPPPPRTLLE ALEQRMERYQ
   361  VAAAQAKSKG DQRKARMHER IVKQYQDAIR AHKAGRAVDV AELPVPPGFP PIQGLEATKP
   421  TQQSLVGVLE TAMKLANQDE GPEDEEDEVP KKQNSPVAPT AQPKAPPSRT PQSGSAPTAK
   481  APPKATSTRA QQQLAFLEGR KKQLLQAALR AKQKNDVEGA KMHLRQAKGL EPMLEASRNG
   541  LPVDITKVPP APVNKDDFAL VQRPGPGLSQ EAARRYGELT KLIRQQHEMC LNHSNQFTQL
   601  GNITETTKFE KLAEDCKRSM DILKQAFVRG LPTPTARFEQ RTFSVIKIFP DLSSNDMLLF
   661  IVKGINLPTP PGLSPGDLDV FVRFDFPYPN VEEAQKDKTS VIKNTDSPEF KEQFKLCINR
   721  SHRGFRRAIQ TKGIKFEVVH KGGLFKTDRV LGTAQLKLDA LEIACEVREI LEVLDGRRPT
   781  GGRLEVMVRI REPLTAQQLE TTTERWLVID PVPAAVPTQV AGPKGKAPPV PAPARESGNR
   841  SARPLHSLSV LAFDQERLER KILALRQARR PVPPEVAQQY QDIMQRSQWQ RAQLEQGGVG
   901  IRREYAAQLE RQLQFYTEAA RRLGNDGSRD AAKEALYRRN LVESELQRLR R

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against CC2D1A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.45
Highest tissue expression
40 nTPM

Expression across tissuesHPA

Tissue

  • cerebellum: 40 nTPM
  • cerebral cortex: 32 nTPM
  • hypothalamus: 32 nTPM
  • colon: 31 nTPM
  • skin: 30 nTPM
  • pancreas: 29 nTPM

Single-cell type

  • tuft cells: 58 nCPM
  • brain excitatory neurons: 57 nCPM
  • other brain neurons: 53 nCPM
  • brain inhibitory neurons: 52 nCPM
  • oligodendrocyte progenitor cells: 47 nCPM
  • astrocytes: 46 nCPM

Immune cell

  • eosinophil: 0.8 nTPM
  • intermediate monocyte: 0.7 nTPM
  • basophil: 0.5 nTPM
  • non-classical monocyte: 0.5 nTPM
  • gdT-cell: 0.4 nTPM
  • myeloid DC: 0.4 nTPM

Brain region

  • hypothalamus: 17 nTPM
  • cerebral cortex: 16 nTPM
  • pons: 15 nTPM
  • basal ganglia: 14 nTPM
  • midbrain: 14 nTPM
  • medulla oblongata: 14 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about CC2D1A.

Disease | AllUniProt

Conditions CC2D1A is implicated in, by any mechanism.

Disease | GeneticClinVar

63 pathogenic / likely-pathogenic of 741 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.42
gnomAD pLI
0.01
gnomAD missense Z
0.94
DepMap mean gene effect
-0.03
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of CC2D1A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads CC2D1A as an antibody target. Whether an autoantibody or antibody against CC2D1A could matter depends on whether native CC2D1A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

CC2D1A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label CC2D1A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/CC2D1A. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...